Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055015 · ClinicalTrials.gov registry record · Phase 3
Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty
A Phase 3 study, sponsored by QRxPharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 141
- Enrollment target
NCT01055015: Completed Phase 3 study, sponsored by QRxPharma.
NCT01055015 is a Phase 3 study that has completed, run by QRxPharma. The registered enrollment target is 141 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055015, a Phase 3 study, has completed, sponsored by QRxPharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 141 participants
- Enrollment target
Study Summary
This is a Phase 3, two-arm, double-blind study of efficacy and safety of Q8003 in patients who have undergone primary unilateral total knee arthroplasty
Interventions
- DRUG Flexible dose Q8003 (morphine sulfate and oxycodone hydrochloride)
- DRUG Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
What the finished NCT01055015 record still lists
NCT01055015 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Flexible dose Q8003 (morphine sulfate and oxycodone hydrochloride) is the first listed.
NCT01055015 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01055015 about?
NCT01055015 is a clinical study titled "Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty". This is a Phase 3, two-arm, double-blind study of efficacy and safety of Q8003 in patients who have undergone primary unilateral total knee arthroplasty
What is the current status of trial NCT01055015?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 141 participants. The study started on 2010-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01055015?
The interventions under investigation include: Flexible dose Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG), Low dose Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG).
Who is sponsoring clinical trial NCT01055015?
This trial is sponsored by QRxPharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01055015's enrollment target sits among peer trials
141 1563rd of 2000 higher than 436 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia